AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
16 hedge funds and large institutions have $152M invested in Ambrx Biopharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$25.9M |
2 |
AG
2
Artal Group
Luxembourg
|
$19.4M |
3 |
SCM
3
Suvretta Capital Management
New York
|
$9.55M |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$17.4M |
5 |
5
Renaissance Technologies
New York
|
$107K |